The acute care and toxicities workstream focus on people at all stages of disease to address their acute symptoms, the acute toxicities of their treatment and the psychosocial impacts of treatment. We are particularly interested in prehabilitation and challenges in the primary-secondary care interface.


  1. Seek opportunities for mechanistic research in understanding and predicting patient outcomes, as part of the drive towards ‘personalised’ or ‘stratified’ medicine in oncology. It will work towards including translational research questions in studies wherever relevant and seek additional funding to answer these accordingly.
  2. Work with NIHR & NCRI to scope the current clinical trials portfolio to identify potential areas for collaboration with other NCRI site specific groups
  3. Meet with a range of site-specific cancer charities to scope potential areas for research. Alliances and collaborations will be built with groups such as NCRI Consumer Forum and charities such as Independent Cancer Patients’ Voice and NCRI Partner charities
  4. Develop research proposals in the following areas:
    • Improve acute oncology pathways of care.
    • Improve care to patients with cancer who may experience acute toxicities of treatment,
    • Focus research to understand the predictive factors which may influence toxicities of treatment.
    • Ameliorate the symptoms caused by their cancer, improving the care and support of patients who complete their treatment and need support with self-management in primary care setting.
    • Extending prehabilitation to optimise all therapies and treatments.
    • Studies to address the psychological impact of treatments or adjustment to surveillance post completing definite treatment.
  5. Develop a leaflet explaining what acute care and toxicities is, who the group members are and what we do to increase engagement with the group.